AlphaLens
Research
财报UnderweightTP $2.50005月14日 · Morgan Stanley

Kindercare 1Q26 Beat on Revenue, but Soft Enrollment and Impending Closures Cloud Outlook

中文EN⚠ quality lint: see notes

Kindercare 1Q26 Beat on Revenue, but Soft Enrollment and Impending Closures Cloud Outlook

Core Conclusion

Kindercare’s 1Q26 revenue beat a low bar by 50 bps, but the beat was driven by one-time items, not operational improvement. Enrollment declined 3%, pricing slowed to 2.2%, and occupancy fell 310 bps YoY — all below full-year guidance. Management signaled above-normal center closures (>15–20 vs. typical 1% of centers), which will pressure revenue growth in 2026/2027. Adj. EBITDA guidance was raised modestly, but 2Q guidance missed consensus. The stock trades at 4x 2026 adj. EV/EBITDA (vs. BFAM at 10x and low-growth services peers at 11x), reflecting structural headwinds. We maintain Underweight with a $2.50 price target.

Revenue Beat Masked by Weak Underlying KPIs

Conclusion: Revenue growth of 0.6% was 50 bps above estimates, but quality was poor. Early Childhood Education (ECE) revenue declined 0.8% vs. guidance expectations of -0.8% to -1.1%, driven by 2.2% pricing (below FY guide) and a 3% enrollment decline (also below guide). Occupancy of 66.0% fell 310 bps YoY, though the sequential decline moderated from 340 bps in 4Q25.

Evidence: Revenue variance of $672.5M vs. MSe $669.5M. ECE revenue $610.2M vs. MSe $608.4M. Champions (before & after school) grew 17% vs. MSe 15%, but this is a smaller segment ($62.4M vs. $610M ECE). Paid-search marketing showed a 15% inquiry increase in targeted centers, but those were only low-single-digit percent of total centers.

Investment implication: The beat is not a sign of recovery. Enrollment and pricing trends remain weak, and occupancy is still well below 70%. Revenue growth in 2026 will be negative (-1.4% guided) without organic lift.

Elevated Center Closures – Near-Term Revenue Headwind, Long-Term Margin Opportunity

Conclusion: Management reviewed its portfolio and plans to close more than the typical 1% (15–20 centers) annually. Each 1% closure typically reduces revenue by ~60 bps. The expected closure rate implies a ~60-90 bps revenue drag in 2026/2027. However, closing underperforming centers could improve occupancy and margins over time.

Evidence: Guidance does not incorporate the full impact of closures; the revenue guide of $2,700-$2,750M was left unchanged despite management’s comments. The 2Q revenue guide midpoint of -0.7% is 234 bps below prior MSe and 112 bps below consensus, suggesting closures already affecting near-term.

Investment implication: Revenue forecasts likely too high. The closure cycle, while necessary for utilization, creates a headwind that limits top-line recovery. Occupancy could improve as low-performing centers are removed, but margin expansion will take time.

Guidance Raised Modestly, But 2Q Woes Signal Slow Recovery

Conclusion: Adj. EBITDA beat by 14% in 1Q, leading to a $5M/33% raise in FY adj. EBITDA/EPS guidance. But 2Q guidance came in well below estimates: revenue midpoint $695M (-0.7% vs. prior MSe +1.6%) and adj. EBITDA midpoint $65M (11% below MSe, 5% below consensus). Management noted recovery “will take time.”

Evidence: FY26 adj. EBITDA guidance raised from $220M to $225M midpoint; adj. EPS from $0.15 to $0.20. However, revenue guide unchanged. 2Q revenue guide $690-$700M implies negative growth; adj. EBITDA margin 9.7% vs. prior MSe 10.2%.

Investment implication: The 1Q beat was not extrapolated; 2Q guides imply the near-term pain continues. We see downside to consensus estimates. Our FY26 adj. EBITDA (ex-SBC) estimate is $204.5M, ~5% below the raised guidance midpoint.

Risks & Valuation

Risks to the downside: Enrollment weakness prolonged; government funding cuts (35% of revenue via childcare subsidies); wage inflation; sponsor overhang from KLC’s private equity ownership.

Valuation: DCF-based base case $4 (5x 2027 adj. EBITDA), bear case $1 (6x bear case EBITDA). PT of $2.50 is midpoint. At current $4.37, the stock is above our fair value. Target multiple 4x 2026 adj. EV/EBITDA vs. BFAM 10x and low-growth services peers 11x. Limited catalysts for re-rating until enrollment stabilizes.

Trade implication: Maintain Underweight. We see better risk/reward in other services names (ARMK, CPG-L). KLC’s recovery is likely a multi-year process; current valuation does not adequately reflect revenue headwinds from closures and weak demand.


Appendix: Key Financial Summary

($M)1Q26 ActualMSeVariance2Q26 Guide MidPrior MSeDiff
Revenue672.5669.5+0.5%695698-0.4%
Adj. EBITDA52.145.6+14.3%6573-10.8%
Adj. EPS$0.04($0.01)n/an/an/an/a

Related (同 ticker)